Integrating microbial taxa with the same filtration as stated above (at the genus level from 16S amplicon sequencing and species level from metagenomic sequencing) and cytokine data and fecal metabolomic data, respectively, was conducted with GFLASSO (R package: GFLASSO, v0.0.0.9000)
What would move this position is: a randomised, placebo-controlled trial in a defined population with an objective primary endpoint, a pre-registered protocol, and pharmacovigilance over a clinically meaningful duration
Whilst no confirmed link exists between Wegovy and body odour in clinical trials, metabolic changes during weight losssuch as fat breakdown releasing ketonesmay indirectly affect body odour
Outline icons set depicting GLP-1 side effects, nausea, diarrhea, decreased appetite, dizziness, injection site reaction